Inspire Medical Systems logo
INSP logo

Inspire Medical SystemsNYSE:INSP Stock Report

Market Cap US$5.3b
Share Price
n/a
1Y-4.0%
7D-4.7%
Portfolio Value
View

Inspire Medical Systems, Inc.

NYSE:INSP Stock Report

Market Cap: US$5.3b

INSP Stock Overview

A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. More details

INSP fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$238.80
FV
25.3% undervalued intrinsic discount
18.69%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
23 days ago author updated this narrative

My Notes

Capture your thoughts, links and company narrative

Inspire Medical Systems, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Inspire Medical Systems
Historical stock prices
Current Share PriceUS$178.39
52 Week HighUS$257.40
52 Week LowUS$123.00
Beta1.32
1 Month Change-3.62%
3 Month Change-5.48%
1 Year Change-3.96%
3 Year Change-23.97%
5 Year Change101.55%
Change since IPO614.13%

Recent News & Updates

Returns At Inspire Medical Systems (NYSE:INSP) Are On The Way Up

Jan 21
Returns At Inspire Medical Systems (NYSE:INSP) Are On The Way Up

Recent updates

Returns At Inspire Medical Systems (NYSE:INSP) Are On The Way Up

Jan 21
Returns At Inspire Medical Systems (NYSE:INSP) Are On The Way Up

Getting In Cheap On Inspire Medical Systems, Inc. (NYSE:INSP) Might Be Difficult

Dec 11
Getting In Cheap On Inspire Medical Systems, Inc. (NYSE:INSP) Might Be Difficult

Inspire Medical Systems: Getting Cheaper But Not There Yet

Nov 23

Inspire Medical Systems, Inc. Just Recorded A 894% EPS Beat: Here's What Analysts Are Forecasting Next

Nov 07
Inspire Medical Systems, Inc. Just Recorded A 894% EPS Beat: Here's What Analysts Are Forecasting Next

A Look At The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)

Oct 31
A Look At The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)

Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?

Oct 03
Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?

After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar

Aug 08
After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar

Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?

Jul 17
Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?

At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?

Jun 22
At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?

Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

May 09
Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

Inspire Medical Systems: A Potential Example Of Market Mispricing

Apr 05

Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Mar 27
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Mar 06
Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical: A Good Night Sleep

Feb 08

Inspire Medical Systems: Time To Wake Up

Nov 17

Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth

Oct 25

Inspire Medical Systems: Excellent Execution And Reset Valuation

Aug 17

Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment

Jul 19

Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating

Jun 15

Shareholder Returns

INSPUS Medical EquipmentUS Market
7D-4.7%0.2%-0.4%
1Y-4.0%11.1%20.8%

Return vs Industry: INSP underperformed the US Medical Equipment industry which returned 11.6% over the past year.

Return vs Market: INSP underperformed the US Market which returned 23.7% over the past year.

Price Volatility

Is INSP's price volatile compared to industry and market?
INSP volatility
INSP Average Weekly Movement6.8%
Medical Equipment Industry Average Movement8.0%
Market Average Movement6.0%
10% most volatile stocks in US Market18.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: INSP has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: INSP's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20071,246Tim Herbertwww.inspiresleep.com

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.

Inspire Medical Systems, Inc. Fundamentals Summary

How do Inspire Medical Systems's earnings and revenue compare to its market cap?
INSP fundamental statistics
Market capUS$5.30b
Earnings (TTM)US$53.51m
Revenue (TTM)US$802.80m

98.9x

P/E Ratio

6.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
INSP income statement (TTM)
RevenueUS$802.80m
Cost of RevenueUS$122.99m
Gross ProfitUS$679.82m
Other ExpensesUS$626.31m
EarningsUS$53.51m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.80
Gross Margin84.68%
Net Profit Margin6.67%
Debt/Equity Ratio0%

How did INSP perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/20 12:01
End of Day Share Price 2025/02/20 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Inspire Medical Systems, Inc. is covered by 23 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael PolarkBaird
David RescottBaird
Ravi MisraBerenberg